PHARMACEUTICAL PRODUCT DEVELOPMENT INC Stock-Based Compensation
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Stock-Based Compensation of $15.33 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $4.66M, a 14.17% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was $4.85M, a 21.24% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for the quarter ending 2011-03-31 was $5.83M, a 3.13% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for the quarter ending 2010-12-31 was $5.53M, a 13.67% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for fiscal 2010 was $19.26M, a 0.20% increase from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for fiscal 2009 was $19.22M, a 21.86% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC share-based payment arrangement, noncash expense for fiscal 2008 was $24.60M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2011-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $9.50M derived: sum of 2 quarters · filed 2011-11-02 | $15.33M 10-Q · filed 2011-11-02 | $20.86M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $10.68M 10-Q · filed 2011-08-04 | $16.20M derived: sum of 3 quarters · filed 2011-08-04 | $20.28M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $5.83M 10-Q · filed 2011-05-03 | $11.36M derived: sum of 2 quarters · filed 2011-05-03 | $15.44M derived: sum of 3 quarters · filed 2011-11-02 | $19.43M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $9.61M derived: sum of 2 quarters · filed 2011-11-02 | $13.61M derived: sum of 3 quarters · filed 2011-11-02 | $19.26M 10-K · filed 2011-02-25 |
| 2010-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $8.08M derived: sum of 2 quarters · filed 2011-11-02 | $13.73M 10-Q · filed 2011-11-02 | $18.59M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $9.65M 10-Q · filed 2011-08-04 | $14.51M derived: sum of 3 quarters · filed 2011-08-04 | $19.12M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $5.65M 10-Q · filed 2011-05-03 | $10.52M derived: sum of 2 quarters · filed 2011-05-03 | $15.12M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $9.47M derived: sum of 2 quarters · filed 2011-02-25 | $19.22M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $4.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $14.35M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $9.75M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $24.60M 10-K · filed 2011-02-25 |